PA40252: Pharmacology of regenerative medicine
Academic Year: | 2019/0 |
Owning Department/School: | Department of Pharmacy & Pharmacology |
Credits: | 6 [equivalent to 12 CATS credits] |
Notional Study Hours: | 120 |
Level: | Masters UG & PG (FHEQ level 7) |
Period: |
|
Assessment Summary: | EX-TH 100%* |
Assessment Detail: |
*Assessment updated due to Covid-19 disruptions |
Supplementary Assessment: |
|
Requisites: | |
Description: | Aims: The aims of this unit are to develop an understanding of the fundamental aspects of adult and embryonic stem cell biology and to develop knowledge of how stem cells and their progeny can be used in both basic research, development of cellular therapies and drug discovery. Learning Outcomes: On successful completion of this unit, the student should be able to: synthesise an in-depth knowledge of the current status of stem cell research, evaluate critically the potential of stem cells and their progeny in particular therapeutic areas and utilise a range of ICT and cognitive skills in acquiring knowledge and understanding and applying them to complex, incomplete or contradictory situations. Skills: Scientific skills (T/F/A) Study skills, handling information, working with others (T/F) Problem solving (T/F). Content: Fundamental aspects of stem cell biology will be covered first, including normal function, maintenance of self-renewal and control of differentiation. The biology of embryonic and adult stem cells will be discussed along with the role of stem cells in cancer. The prospects and challenges for the use of stem cells as new therapeutic options to treat a range of chronic degenerative and inflammatory diseases as well as drug targets will be discussed. |
Programme availability: |
PA40252 is Optional on the following programmes:Department of Pharmacy & Pharmacology
|
Notes:
|